BDBM508735 3,4-Dichlorophenyl 3-deoxy-3-[4-(4-hydroxythiazol-2-yl)-1H-1,2,3-triazol-1-yl]-1-thio-α-D-galactopyranoside::US11046725, Example 11

SMILES OCC1O[C@H](Sc2ccc(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1nc(O)cs1

InChI Key InChIKey=KRFOHZKKGPUCCZ-AHXITHOBSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 508735   

TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508735(3,4-Dichlorophenyl 3-deoxy-3-[4-(4-hydroxythiazol-...)
Affinity DataKd:  1.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508735(3,4-Dichlorophenyl 3-deoxy-3-[4-(4-hydroxythiazol-...)
Affinity DataKd:  650nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent